Colorectal cancer vaccines

Principles, results, and perspectives

Simone Mocellin, Carlo Riccardo Rossi, Mario Lise, Donato Nitti

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

In the search for novel therapeutic approaches to treat patients with colorectal carcinoma, anticancer vaccination holds promise. A large body of preclinical and clinical evidence has demonstrated that the immune system can be polarized against malignant cells by means of several active specific immunotherapy strategies. Although no vaccination regimen can be currently recommended outside clinical trials, tumor response and immunologic findings observed in animal models and humans prompt researchers to explore further the antitumor potential of such biotherapy in an effort to reproduce in a larger set of patients the cascade of molecular events that characterizes the successful tumor immune rejection currently observed in a minority of vaccinated subjects. In this work, we summarize the principles and the main results of cancer vaccine strategies so far implemented for the treatment of patients with colorectal carcinoma. We also discuss the most recent preclinical tumor immunology insights that might change the way to design the next generation of cancer vaccines, hopefully improving the effectiveness of such a biotherapeutic approach.

Original languageEnglish
Pages (from-to)1821-1837
Number of pages17
JournalGastroenterology
Volume127
Issue number6
DOIs
Publication statusPublished - Dec 2004

Fingerprint

Cancer Vaccines
Colorectal Neoplasms
Vaccination
Active Immunotherapy
Neoplasms
Biological Therapy
Allergy and Immunology
Immune System
Animal Models
Research Personnel
Clinical Trials
Therapeutics

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Colorectal cancer vaccines : Principles, results, and perspectives. / Mocellin, Simone; Rossi, Carlo Riccardo; Lise, Mario; Nitti, Donato.

In: Gastroenterology, Vol. 127, No. 6, 12.2004, p. 1821-1837.

Research output: Contribution to journalArticle

Mocellin, Simone ; Rossi, Carlo Riccardo ; Lise, Mario ; Nitti, Donato. / Colorectal cancer vaccines : Principles, results, and perspectives. In: Gastroenterology. 2004 ; Vol. 127, No. 6. pp. 1821-1837.
@article{03e484b2efd44bd9b7c0dcd0dd94d138,
title = "Colorectal cancer vaccines: Principles, results, and perspectives",
abstract = "In the search for novel therapeutic approaches to treat patients with colorectal carcinoma, anticancer vaccination holds promise. A large body of preclinical and clinical evidence has demonstrated that the immune system can be polarized against malignant cells by means of several active specific immunotherapy strategies. Although no vaccination regimen can be currently recommended outside clinical trials, tumor response and immunologic findings observed in animal models and humans prompt researchers to explore further the antitumor potential of such biotherapy in an effort to reproduce in a larger set of patients the cascade of molecular events that characterizes the successful tumor immune rejection currently observed in a minority of vaccinated subjects. In this work, we summarize the principles and the main results of cancer vaccine strategies so far implemented for the treatment of patients with colorectal carcinoma. We also discuss the most recent preclinical tumor immunology insights that might change the way to design the next generation of cancer vaccines, hopefully improving the effectiveness of such a biotherapeutic approach.",
author = "Simone Mocellin and Rossi, {Carlo Riccardo} and Mario Lise and Donato Nitti",
year = "2004",
month = "12",
doi = "10.1053/j.gastro.2004.07.012",
language = "English",
volume = "127",
pages = "1821--1837",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Colorectal cancer vaccines

T2 - Principles, results, and perspectives

AU - Mocellin, Simone

AU - Rossi, Carlo Riccardo

AU - Lise, Mario

AU - Nitti, Donato

PY - 2004/12

Y1 - 2004/12

N2 - In the search for novel therapeutic approaches to treat patients with colorectal carcinoma, anticancer vaccination holds promise. A large body of preclinical and clinical evidence has demonstrated that the immune system can be polarized against malignant cells by means of several active specific immunotherapy strategies. Although no vaccination regimen can be currently recommended outside clinical trials, tumor response and immunologic findings observed in animal models and humans prompt researchers to explore further the antitumor potential of such biotherapy in an effort to reproduce in a larger set of patients the cascade of molecular events that characterizes the successful tumor immune rejection currently observed in a minority of vaccinated subjects. In this work, we summarize the principles and the main results of cancer vaccine strategies so far implemented for the treatment of patients with colorectal carcinoma. We also discuss the most recent preclinical tumor immunology insights that might change the way to design the next generation of cancer vaccines, hopefully improving the effectiveness of such a biotherapeutic approach.

AB - In the search for novel therapeutic approaches to treat patients with colorectal carcinoma, anticancer vaccination holds promise. A large body of preclinical and clinical evidence has demonstrated that the immune system can be polarized against malignant cells by means of several active specific immunotherapy strategies. Although no vaccination regimen can be currently recommended outside clinical trials, tumor response and immunologic findings observed in animal models and humans prompt researchers to explore further the antitumor potential of such biotherapy in an effort to reproduce in a larger set of patients the cascade of molecular events that characterizes the successful tumor immune rejection currently observed in a minority of vaccinated subjects. In this work, we summarize the principles and the main results of cancer vaccine strategies so far implemented for the treatment of patients with colorectal carcinoma. We also discuss the most recent preclinical tumor immunology insights that might change the way to design the next generation of cancer vaccines, hopefully improving the effectiveness of such a biotherapeutic approach.

UR - http://www.scopus.com/inward/record.url?scp=9644303122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9644303122&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2004.07.012

DO - 10.1053/j.gastro.2004.07.012

M3 - Article

VL - 127

SP - 1821

EP - 1837

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 6

ER -